A study is presented on effects of the adenovirus-mediated human bone morphogenetic protein-2 (Ad-BMP-2) expression vector's transfection into rabbit bone marrow stromal cells (rBMSCs) and the subsequent composition to nanohydroxyapatite (Nano-HA) for the construction of biomimetic artificial bone in vitro. The adenovirus vector was constructed by Gateway TM technology, and the rBMSCs transfected by Ad-BMP-2 were cultured in vitro. Immunohistochemistry, reverse transcriptase-polymerase chain reaction and Western blot were used to detect the bone morphogenetic protein-2 (BMP-2) expression. After culture for 48 h, the transfected cells were seeded onto the Nano-HA scaffold. Scanning electron microscopy (SEM) was used to observe the growth and attachment of cells on the composite scaffold on the third and fifth days. After transfection, the hBMP-2 gene showed high expressions in mRNA and protein levels. SEM revealed even distribution and fine adherence of the cells in the composite scaffold. The Western blot showed high expression of BMP-2 in the transfected and compound cells. The target cells that were transfected with the adenovirus vector that contained the genes, were bonded to the Nano-HA scaffold, and therefore the cell carrier complexes became stable and effectively secreted growth factors, and the biomimetic artificial bones were successfully constructed in vitro.

References

1. 1)
  - 10. Chunsong, H., Dahu, W., Jingye, M.: ‘Types and development trends of bone tissue engineering scaffold material’, J. Clin. Rehabilitative Tissue Eng. Res., 2009, 25, pp. 4905–4908.
2. 2)
  - 2. Ishihara, A., Zekas, L.J., Weisbrode, S.E., et al: ‘Comparative efficacy of dermal fibroblast-mediated and direct adenoviral bone morphogenetic protein-2 gene therapy for bone regeneration in an equine rib model’, Gene Ther., 2010, 6, pp. 733–744 (doi: 10.1038/gt.2010.13).
3. 3)
  - 6. Hartman, Z.C., Appledom, D.M., Amalfitaao, A.: ‘Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications’, Vires Res., 2008, 132, pp. l–14.
4. 4)
  - 13. Hui, Q., Jianzhong, X., Qiang, Z., et al: ‘Effects of two construction methods on adhesion and proliferation of tissue engineering bone seed cells’, J. Third Military Medical University, 2004, 26, pp. 990–992.
5. 5)
  - 5. Liangquan, P., Daping, W., Ke, Z., et al: ‘Construction and identification of adenovirus vector of recombinant human bone morphogenetic protein-2’, J. Clin. Rehabilitative Tissue Eng. Res., 2009, 25, pp. 3942–3946.
6. 6)
  - 15. Gustafsson, Y., Haag, J., Jungebluth, P., et al: ‘Viability and proliferation of rat MSCs on adhesion protein-modified PET and PU scaffolds’, Biomaterials, 2012, 11, pp. 8094–8103 (doi: 10.1016/j.biomaterials.2012.07.060).
7. 7)
  - 7. Xinsheng, Z., Xiaoyu, L., Shuangyi, R.: ‘Discovery of green fluorescent protein and its application’, J. Dalian Medical University, 2009, 31, pp. 342–345.
8. 8)
  - 1. Evans, C.H., Ghivizzani, S.C., Robbins, P.D.: ‘Orthopaedic gene therapy’, Clin. Orthop. Relat. Res., 2004, (429), pp. 316–329 (doi: 10.1097/01.blo.0000148854.14399.ec).
9. 9)
  - 14. Hosseinkhani, H., Yamamoto, M., lnatsug, Y.: ‘Enhanced ectopic bone formation using a combination of plasmid DNA impregnating into 3D scaffold and bioreaetor perfusion culture’, Biomaterials, 2006, 27, pp. 1387–1398 (doi: 10.1016/j.biomaterials.2005.08.017).
10. 10)
  - 4. Wu, D., Razzano, P., Grande, D.A.: ‘Gene therapy and tissue engineering in repair of the musculoskeletal system’, J. Cell Biochem., 2003, 88, p. 467481.
11. 11)
  - 3. Zhang, W., Tsurushima, H., Oyane, A., et al: ‘BMP-2 gene-fibronectin-apatite composite layer enhances bone formation’, J. Biomed. Sci., 2011, 18, pp. 62–72 (doi: 10.1186/1423-0127-18-62).
12. 12)
  - 11. Zhu, W.M., Xiao, J.D., Wang, D.P., et al: ‘Experimental study of Nano-HA artificial bone with different pore sizes for repairing the radial defect’, Int. Orthop., 2009, 33, (2), pp. 567–571 (doi: 10.1007/s00264-008-0572-5).
13. 13)
  - 8. Steiehler, M., Seib, F.P., Rauh, J., et al: ‘Cancellous bone allograft seeded with human mesenchymal stromal cells, a potential good manufacturing practice-grade tool for the regeneration of bone defects’, Cytotherapy, 2010, 9, pp. 658–668 (doi: 10.3109/14653241003774052).
14. 14)
  - 9. Liangquan, P., Daping, W., Chunlei, H., et al: ‘Separation, culture and identification of human bone mesenchymal stem cells, culture and characterization’, Chin. J. Clin. Anat., 2009, 27, pp. 321–324.
15. 15)
  - 12. Yang, X.-F., He, X., He, J., et al: ‘High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells’, J. Biomed. Sci., 2011, 18, pp. 59–67 (doi: 10.1186/1423-0127-18-59).

Study on transfection of bone morphogenetic protein-2 gene into rabbit bone marrow stromal cells and composition to nanohydroxyapatite for constructing tissue engineered bones

References

Related content